IP

Intellectus Partners Portfolio holdings

AUM $578M Turnover 15.36%
1-Year Est. Return 49.48%
This Fund
S&P 500
This Quarter Est. Return
+7.3%
1 Year Est. Return
+49.48%
3 Year Est. Return
+157.34%
5 Year Est. Return
+153.66%
10 Year Est. Return
–
AUM
$443M
AUM Growth
+$79.4M
Cap. Flow
+$58.1M
Cap. Flow %
13.09%
Top 10 Hldgs %
28.62%
Holding
280
New
38
Increased
121
Reduced
93
Closed
8
Avg Time Held Equity + Options
1.8 years
Top 10 Avg Time Held Equity + Options
1.9 years
Top 20 Avg Time Held Equity + Options
2 years
Avg Time Held Equity only
1.9 years
Top 10 Avg Time Held Equity only
1.9 years
Top 20 Avg Time Held Equity only
2 years

Sector Composition

Rank Sector Weight
1 Miscellaneous 19.51%
2 Healthcare 19.33%
3 Technology 19.31%
4 Consumer Discretionary 12.84%
5 Communication Services 8.56%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
FOXF icon
251
Fox Factory Holding Corp
FOXF
$729M
$233K 0.05%
1,495
-180
-11% -$26.8K
2021 Q1
1 quarter
PARA icon
252
DELISTED
Paramount Global Class B
PARA
$227K 0.05%
+5,000
New +$206K
2021 Q2
0 quarters
EBAY icon
253
eBay
EBAY
$51.8B
$221K 0.05%
+3,145
New +$197K
2021 Q2
0 quarters
NXU.U icon
254
DELISTED
Novus Capital Corporation II Units, each consisting of one share of Class A common stock and one thi
NXU.U
$207K 0.05%
+20,500
New +$207K
2021 Q2
0 quarters
ABCL icon
255
PUT
AbCellera Biologics
ABCL
$4.03B
$189K 0.04%
+67,200
New +$1.85M
2021 Q2
0 quarters
PZC
256
DELISTED
PIMCO California Municipal Income Fund III
PZC
$184K 0.04%
15,950
-2,000
-11% -$22.1K
2020 Q2
4 quarters
ABCL icon
257
CALL
AbCellera Biologics
ABCL
$4.03B
$158K 0.04%
+70,100
New +$1.93M
2021 Q2
0 quarters
BLRX icon
258
BioLineRX
BLRX
$10.7M
$114K 0.03%
1,013
– –
2021 Q1
1 quarter
CMU
259
DELISTED
MFS High Yield Municipal Trust
CMU
$80K 0.02%
16,818
– –
2020 Q4
2 quarters
NUVB.WS icon
260
DELISTED
Nuvation Bio Inc Warrants
NUVB.WS
$69K 0.02%
+26,414
New +$86.1K
2021 Q2
0 quarters
SFTW.WS
261
DELISTED
Osprey Technology Acquisition Corp. Redeemable Warrants, each whole Warrant exercisable for one shar
SFTW.WS
$51K 0.01%
+30,012
New +$42.8K
2021 Q2
0 quarters
CLOV icon
262
CALL
Clover Health Investments
CLOV
$2.56B
$28K 0.01%
+14,900
New +$146K
2021 Q2
0 quarters
VSAT icon
263
CALL
Viasat
VSAT
$8.32B
$21K ﹤0.01%
+12,500
New +$621K
2021 Q2
0 quarters
SLV icon
264
CALL
iShares Silver Trust
SLV
$27B
$19K ﹤0.01%
+12,500
New +$310K
2021 Q2
0 quarters
BCTXW icon
265
DELISTED
BriaCell Therapeutics Corp Warrant
BCTXW
$18K ﹤0.01%
+10,000
New +$12.5K
2021 Q2
0 quarters
PXSAW
266
DELISTED
Pyxis Tankers Inc Warrant
PXSAW
$13K ﹤0.01%
32,000
– –
2020 Q4
2 quarters
HCDIW
267
DELISTED
Harbor Custom Development, Inc. Warrant
HCDIW
$13K ﹤0.01%
+21,000
New +$14.8K
2021 Q2
0 quarters
BIL icon
268
State Street SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
$50.8B
$0 ﹤0.01%
19,000
+3,000
+19% +$274K
2019 Q2
8 quarters
BLK icon
269
Blackrock
BLK
$166B
– –
-474
Closed -$357K –
EFR icon
270
Eaton Vance Senior Floating-Rate Fund
EFR
$302M
– –
-37,242
Closed -$514K –
NCV icon
271
Virtus Convertible & Income Fund
NCV
$340M
– –
-3,254
Closed -$74K –
QQQ icon
272
Invesco QQQ Trust
QQQ
$487B
– –
-2,967
Closed -$947K –
RXD icon
273
ProShares UltraShort Health Care
RXD
$3.37M
– –
-48,750
Closed -$79K –
SHY icon
274
iShares 1-3 Year Treasury Bond ETF
SHY
$26.8B
– –
-3,113
Closed -$268K –
SPCE icon
275
Virgin Galactic
SPCE
$388M
– –
-1,791
Closed -$1.1M –

Similar funds

Intellectus Partners's Q2 2021 Portfolio in Review

As of Q2 2021, Intellectus Partners held 280 positions worth $443M, up 22% from $364M the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Intellectus Partners deployed $58.1M of net new capital in Q2 2021, opening 38 new positions and adding to 121 existing holdings. Its largest new stake was AbCellera Biologics: 1,206,979 shares worth $26.6M.

By sector, the portfolio is most concentrated in Miscellaneous at 20% of assets, down from 22% a quarter earlier, followed by Healthcare and Technology.

On the sell side, the largest reduction was Intellia Therapeutics, an estimated $1.79M trimmed.

  • Intellectus Partners's largest Q2 2021 buy was AbCellera Biologics: 1,206,979 shares worth $26.6M.
  • Intellectus Partners added most to iShares Silver Trust in Q2 2021, an estimated $1.54M increase.
  • Intellectus Partners's biggest Q2 2021 reduction was Intellia Therapeutics, cutting an estimated $1.79M.
  • Intellectus Partners fully exited Virgin Galactic in Q2 2021, selling an estimated $1.1M.
  • Intellectus Partners's ten largest holdings make up 29% of its $443M portfolio in Q2 2021.
  • Intellectus Partners opened 38 new positions and closed 8 in Q2 2021.
  • Intellectus Partners's portfolio value rose 22% quarter-over-quarter to $443M.

Based on Intellectus Partners's 13F filing for Q2 2021, filed 13 Aug 2021.